PROTEXT MOBILITY, INC.

Press Releases ProText Mobility, Inc.

Equities

TXTM

US74371E2046

Market Closed - OTC Markets Other stock markets 03:59:54 2024-04-26 pm EDT			5-day change	1st Jan Change
0.0023 ^USD	+27.78%		+27.78%	+35.29%

2022	Protext Mobility, Inc and RSAMMDA LLC Provides the Shareholder Update	CI
2021	ProText Mobility, Inc. Provides Updates on Research Conducted At A Licensed Facility	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PROTEXT MOBILITY, INC. (TXTM) ADDRESSES ALLEGED PROMOTIONAL ACTIVITY AND OTC MARKETS CE DESIGNATION	22-11-14	AQ
PROTEXT MOBILITY, INC. (TXTM) AND RSAMMDA LLC (DELAWARE) PROVIDES SHAREHOLDER UPDATE	22-11-01	EQ
PROTEXT MOBILITY, INC. (TXTM) AND RSAMMDA LLC (DELAWARE) PROVIDES SHAREHOLDER UPDATE	22-11-01	AQ
RSAMMD ACQUISITIONS LLC AND PROTEXT MOBILITY, INC. (TXTM) PROVIDE SHAREHOLDERS UPDATE AND NEAR TERM ROAD MAP	22-08-01	AQ
ProText Mobility : Quarterly Report - Protext Q3 2021 - Amended	21-12-02	PU
ProText Mobility : Quarterly Report	21-11-21	PU
ProText Mobility : Notification of Late Filing	21-11-15	PU
PROTEXT MOBILITY ANNOUCNES SIGNING OF LETTER OF INTENT TO ACQUIRE PREMIER VODKA BRAND	21-10-29	AQ
Republic of South Africa Medical Marijuana Dispensaries (RSAMMD) Announces Successful Testing Results of Proprietary Cannabis Plant Extraction Technology with JV Partner Protex Pharma (TXTM)	20-05-07	NE
Republic of South Africa Medical Marijuana Dispensaries (RSAMMD) Signs Letter of Intent with USA-based Protext Pharma (TXTM) for Commercialization of Next Generation Live Cannabis and Hemp Extraction Technology	20-04-30	NE
Protext Pharma to Acquire Cannabis Blockchain Company Growprocess, Inc.	18-01-19	GL
Protext Pharma : Announces South Africa's Reclassification of Cannabis as a Schedule 4 Substance	17-09-20	MW
Protext Pharma : to Conduct Clinical Trial to Determine Therapeutic Dosage Levels for Treating Diabetes	17-09-13	MW
Protext Mobility : Completes Name Change to Protext Pharma and Provides Update on Medical Cannabis License	17-05-23	MW
Protext Mobility : Signs Agreement With Leading Research Center, CIDP, to Conduct Diabetes Human Clinical Trial	17-05-04	MW
Protext Mobility : Announces Acquisition of Cannabis Biosciences Inc.	17-03-27	MW
Protext Mobility : Discusses Potential Effectiveness of Phytofare Green Tea Extract in Treating Type II Diabetes	17-03-07	MW
Protext Mobility : Caps Off Week of Meetings in Mauritius With Visit to State House for Meeting With President Gurib-Fakim	17-03-03	MW
Protext Mobility : TXTM) Launches New Website and Social Media Channel	16-12-12	MW

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer